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Abstract
Three cases of nosocomial malaria are reported from patients of the Internal Medicine Ward of a
tertiary University teaching hospital in Medellin, Colombia. Epidemiological research, based on
entomological captures, medical records review and interviews of nursery staff about patient care
practices potentially involving contact with blood, were carried out. Molecular characterization of
Plasmodium falciparum was based on the amplification of MSP1, MSP2 and GLURP genes. This
method enabled confirmation of the same P. falciparum genotype in all three patients as well as in
a fourth one (index case). The presence of nosocomial malaria was confirmed and it was concluded
that the most likely source of transmission was through multi-dose preparations of heparin applied
to heparin locks.
Background
The city of Medellin is located in the north-western region
of Colombia and, although malaria is endemic in the
country, absence of anophelines within the city makes
vector transmission of the infection impossible. However,
this city, located within the Andes Mountains (6°13'N,
75°36'W) at 1,588 m above sea level (a.s.l.), is sur-
rounded by highly endemic regions and imported cases
are often referred to the University hospital for treatment.
Here, three cases of nosocomial malaria, which occurred
in hospitalized patients in the Internal Medicine Ward of
Hospital A, are described. These patients were being
treated for diverse conditions and they shared the hospital
facilities during different periods. One of these patients
was in the Emergency Ward at the same time as a Plasmo-
dium falciparum-infected patient.
In order to confirm an association between all the cases,
P. falciparum genomic DNA was amplified using specific
primers for polymorphic streches of Merozoite Surface
Antigen-1 (MSP-1), Merozoite Surface Antigen-2 (MSP-2)
and Glutamate Rich Protein (GLURP), and the profile
observed among the different isolates was compared.
Case presentations
Patient 1. Index case
A 23-year-old male woodcutter, resident in Vigia del
Fuerte (6.35N, 76.53W), was referred to the hospital on
11 April 2001, diagnosed with yellow fever. Vigia del
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Fuerte is a highly endemic malaria region located in the
Atrato River basin with a mean Annual Parasite Index
(API) of 72.6 during the past five years. The patient pre-
sented 15 days with fever, headache, chills, jaundice,
arthralgia, melena, dark urine and bilious vomiting. He
was given a heparin lock for administration of I.V. treat-
ment. The patient deteriorated throughout the night and
died before thick smear results were available. Peripheral
blood thin and thick smears confirmed the presence of P.
falciparum asexual forms (>100,000 per µl). A post-mor-
tem confirmed as cause of death complicated malaria.
Dengue and yellow fever IgM antibodies were absent. The
patient remained in the emergency ward for 18 hours
prior to his death.
Patient 2
A 19 year-old male, unemployed, resident in Angelopolis
(Antioquia, 6.06°N 75.42°W), a non-malarious area,
located 1,900 m a.s.l., attended the emergency service of
the hospital on 10th April 2001, and remained there for 24
hours before being transferred to the Internal Medicine
Ward with diagnosis of systemic lupus erythematosus
(SLE). In addition to symptoms and signs of SLE, he pre-
sented fever on 23 April, and received treatment with fen-
itoin, dipirone, ampicillin, ranitidine, ceftriazone,
methilprednisolone, oxacillin, amikacin and enoxaparine
(via an heparin lock). As part of the treatment for his con-
dition, he was administered chloroquine 150 mg daily
from 24th April 2001. He was discharged on 19th May
2001. Then, on 6th June 2001, he was hospitalized with a
diagnosis of a febrile syndrome. P. falciparum malaria was
confirmed on 20th June 2001 after observation of the par-
asite in a blood cell count. A thick smear revealed the pres-
ence of 14,440 asexual forms per µl in peripheral blood.
The patient was administered quinine and sulphadoxine-
pyrimethamine with good treatment response.
Patient 3
A 46 year-old male, unemployed, resident of Santa Bar-
bara (Antioquia, 5.57°N 75.91°W), a non-malarious area
located 1,800 m a.s.l., was hospitalized in the Internal
Medicine Ward on 8th May with diagnosis of status asth-
maticus. He was administered aminophyllin, hydrocorti-
sone, ranitidine, enoxaparine (via a heparin lock) and was
discharged on 15th May 2001. He returned to the hospital
on 5th June 2001 complaining of fever, chills and adyna-
mia and was admitted with diagnosis of toxic hepatitis
due to the presence of dark urine, jaundice and hepatome-
galy. On 6th June 2001, diagnosis of complicated malaria
was confirmed by observation of the parasite in a blood
cell count. Later, the presence of 87,500 trophozoites of P.
falciparum  per  µl was confirmed by a thick smear. He
received treatment with quinine, sulphadoxine-pyrimeth-
amine and was discharged on June 23rd 2001
Patient 4
A 41 year-old male, flower-grower, resident of El Carmen
del Viboral (Antioquia, 6.09°N 75.34°W), a non-malari-
ous area located 2,150 m a.s.l.., was admitted directly to
the Internal Medicine Ward of the hospital on 7th May
2001 with superior vena cava syndrome (100% obstruc-
tion) and was applied a heparin lock for administration of
I.V treatment. The patient was diagnosed with a mediasti-
nal mass, compatible with lymphoma, and received treat-
ment with dexametasone (I.V.) and radiotherapy. On
June 9th 2001, he evidenced fever and on 9th June 2001, he
was diagnosed as complicated malaria by a cell blood
count. A thick smear confirmed the presence of 166,440
asexual forms of P. falciparum per µl. He received treat-
ment with quinine, sulphadoxine-pyrimethamine with
good treatment response. However, on 1st July 2001, he
died as a consequence of multiple non-malaria related
complications.
Entomological captures
Search for Anopheles was carried out by expert personnel
from the Secretariat of Health, both within the ward and
in the surrounding gardens, around the time of malaria
diagnosis of patients 2 and 4. These confirmed the
absence of the vector in the hospital area.
Molecular analysis
P. falciparum genomic DNA was extracted from whole
blood collected onto filter paper or from paraffin
embebbed brain tissue (for the index case). Paraffin was
removed from post-morten material using xylene, fol-
lowed by 2 washes with 100% ethanol. DNA was isolated
by proteinase K digestion, followed by four rounds of
phenol-chloroform extraction. Purified DNA was stored
at -20°C until amplification.
The Region 2 of MSP-1 and the central region of MSP-2
were amplified by a nested Polymerase Chain Reaction
(PCR); the region RII of GLURP was amplified by a semi-
nested PCR [1]. Products obtained after the first PCR were
amplified using specific primers for region 2 of MSP-1 cor-
responding to MAD20, K1 and RO33 allelic families, and
FC27 and IC-1 for the central region of MSP-2. Briefly,
PCR was carried out in a total volume of 20 µL, containing
10 mm Tris-HCl (pH 9,0 at 25°C), 50 mm KCl and 0,1%
Triton X-100, 125 mM dNTPs, 0,4 units Taq DNA
polymerase (Promega, Madison, WI), 1,6 mM MgCl2 and
125 nM of each primer. Initial denaturation was 5 min at
95°C, 1 min at 94°C, 2 min at 58°C annealing (all first
PCR reactions and second reaction for GLURP) or at 61°C
(for all the second reactions of MSP-1 and 2). This was fol-
lowed by extension for 2 minutes at 72°C. This first reac-
tion underwent 25 amplification cycles and the second 30
cycles. Positive (strains HB3, K1 and RO33) and negative
controls (healthy individuals), were included.Malaria Journal 2005, 4:9 http://www.malariajournal.com/content/4/1/9
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Products were electrophoresed on an agarose (MetaPhor)
gel (2,5% for MSP-1 and 2% for MSP-2 and GLURP),
stained with ethidium bromide and visualized under
ultraviolet light. Size analysis of the amplified fragments
revealed identical pattern distribution for all the exam-
ined markers assayed, confirming the presence of P. falci-
parum infection by matching strains in all 4 patients (Fig
1).
Conclusions
The presence of P. falciparum malaria infection in three
patients without history of malaria or travel to malaria-
endemic regions is described. The first of these patients
(Patient 2) shared the Emergency Ward with a fatal case of
falciparum malaria. The incubation period for this noso-
comial infection was 12 days, however, since he was
administered high doses of chloroquine, fever receded for
about two weeks. Resistance of P. falciparum to chloro-
quine is highly prevalent in the Antioquia region [2], this
explains the lack of efficacy of the antimalarial in eradicat-
ing parasites in this patient.
Patient 2 shared the Internal Medicine facilities with
patients 3 and 4 at least for one week during May. Patient
3 evidenced an incubation period of 22 days, while in
Patient 4 this was 26 days.
Since patients 3 and 4 had no contact with the index case,
further analysis of the incubation periods allowed us to
conclude that transmission occurred from index case to
Dates, chronology of exposure, place of contact and time of malaria diagnosis of the index case and the 3 patients with noso- comial malaria Figure 1
Dates, chronology of exposure, place of contact and time of malaria diagnosis of the index case and the 3 patients with noso-
comial malaria. Each bar represents the location of each patient during the stay at the hospital.Malaria Journal 2005, 4:9 http://www.malariajournal.com/content/4/1/9
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Agarose gel electrophoresis showing the size of the amplified products of the genes MSP-1 (panel A), MSP-2 (panel B) and  GLURP (panel C) Figure 2
Agarose gel electrophoresis showing the size of the amplified products of the genes MSP-1 (panel A), MSP-2 (panel B) and 
GLURP (panel C). MW represents the molecular weight marker,(-) a negative control and (+) a positive control. The numbers 
are equivalent to the case number. Panel A corresponds to allelic family MAD-20 of MSP-1 showing amplification products of 
~150 bp in the cases, panel B corresponds to allelic family IC50 showing amplification products of ~450 bp in the cases, panel 
C corresponds to GLURP showing amplification products of ~700 bp in the cases.Publish with BioMed Central    and   every 
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patient 2 and the latter was the source of infection for
patients 3 and 4. This means that at least 2 separate
episodes of contamination were involved in transmission
to the different patients (see figure 2). Since entomologi-
cal captures were negative for vectors and Medellin is not
an area of vector transmission for malaria, parenteral con-
tamination might be the most likely mechanism of trans-
mission. None of the patients was administered blood
before diagnosis of malaria, but all of them had at least
one heparinized lock during their stay either in the Emer-
gency or in the Internal Medicine Ward.
Transmission of malaria via heparin locks has been
reported previously by other authors, the source of con-
tamination was a multidose heparin container [3].
Although the practice of multiple dose preparations of
heparin into large volume syringes to be distributed
among the several patients of the ward is forbidden at this
tertiary institution, it has been difficult to eradicate due to
the high volume of patients and the limited economical
resources of the hospital.
Other researchers have reported on the use of molecular
typing of P. falciparum to confirm nosocomial transmis-
sion of malaria [4]. Genotyping of all 4 cases confirmed
the epidemiological suspicion of nosocomial transmis-
sion. Considering the previous report on the limited
genetic polymorphism of P. falciparum observed in the
Antioquia region [5], the presence of an identical geno-
type of P. falciparum among unrelated parasites may be
possible, but unlikely, since examination of these 3 differ-
ent genes has been routinely used to discriminate unre-
lated parasites [6]. Moreover, the molecular findings
together with the epidemiological characteristics contrib-
ute to confirm nosocomial transmission of the infection.
These observations are of major relevance to sanitary and
health authorities, since they confirm the importance of
biosafety during minor procedures, such as application of
heparin to peripheral locks. In addition, it highlights the
need to rule-out malaria infections in all febrile patients
sharing hospital facilities with malaria patients as well as
in those not responding as expected to antimicrobial
therapy.
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